Teriflunomide is a once-daily oral immunomodulatory disease-modifying treatment for multiple sclerosis (MS). Skin reactions are an infrequent side effect of teriflunomide. Here, we present the case of a 52-year-old female patient with ankylosing spondylitis who was consulted for demyelinating lesions and limb weakness. She was diagnosed with multiple sclerosis and started treatment with teriflunomide. Palmoplantar pustular psoriasis developed after three weeks of treatment initiation. It is a rare side effect related to teriflunomide.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472710 | PMC |
| http://dx.doi.org/10.7759/cureus.42845 | DOI Listing |
Publication Analysis
Top Keywords
palmoplantar pustular
8
pustular psoriasis
8
side teriflunomide
8
teriflunomide-induced palmoplantar
4
psoriasis case
4
case report
4
report review
4
review literature
4
teriflunomide
4
literature teriflunomide
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!